BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6099878)

  • 21. Behavioral and neurochemical changes in long-term hyperprolactinemia.
    Drago F; Continella G; Scapagnini U
    Adv Biochem Psychopharmacol; 1985; 40():47-58. PubMed ID: 3895841
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity.
    Dewey SL; Chaurasia CS; Chen CE; Volkow ND; Clarkson FA; Porter SP; Straughter-Moore RM; Alexoff DL; Tedeschi D; Russo NB; Fowler JS; Brodie JD
    Synapse; 1997 Apr; 25(4):393-8. PubMed ID: 9097399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal behavioral and neurochemical effects of the CNS toxic amino acid antitumor agent, acivicin.
    McGovren JP; Williams MG; Tang AH; VonVoigtlander PF; Piercey MF; Einspahr FJ; Schreur PJ
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):215-29. PubMed ID: 2711026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A permanent dopamine receptor up-regulation in the ovariectomized rat.
    Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1989 May; 33(1):123-5. PubMed ID: 2780771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-dose and escalating-dose "binge" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats.
    Schlussman SD; Zhou Y; Bailey A; Ho A; Kreek MJ
    Brain Res Bull; 2005 Oct; 67(3):169-75. PubMed ID: 16144651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distribution of apomorphine in rat brain: possible behavioral correlates.
    Melzacka M; Wiszniowska G; Vetulani J
    Pol J Pharmacol Pharm; 1978; 30(2-3):335-45. PubMed ID: 566915
    [No Abstract]   [Full Text] [Related]  

  • 29. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on monoamine levels in rat CNS after chronic administration of cocaine.
    Alburges ME; Wamsley JK
    Invest Clin; 1993; 34(4):181-92. PubMed ID: 7516188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of behavioral and neurochemical effects of acute administration of cocaine in rats.
    Pradhan S; Roy SN; Pradhan SN
    Life Sci; 1978 May; 22(19):1737-43. PubMed ID: 27685
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Physiol Behav; 1991 Oct; 50(4):825-30. PubMed ID: 1775558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro.
    Brase DA
    J Pharm Pharmacol; 1980 Jun; 32(6):432-3. PubMed ID: 6106680
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG; Goedemoed JH; Rollema H; Horn AS
    J Pharm Pharmacol; 1983 Jul; 35(7):471-3. PubMed ID: 6136595
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in dopamine receptors in mouse striatum following morphine treatments.
    de la Baume S; Patey G; Marçais H; Protais P; Costentin J; Schwartz JC
    Life Sci; 1979 Jun; 24(25):2333-42. PubMed ID: 573360
    [No Abstract]   [Full Text] [Related]  

  • 38. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of occlusal interference, sedation and centrally acting muscle relaxants on apomorphine-induced oral dyskinesias in rats.
    Pohto P; Sundén-Kuronen B; Alanen E
    Proc Finn Dent Soc; 1979; 75(5-6):85-94. PubMed ID: 575564
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester.
    Scatton B; Worms P
    J Pharm Pharmacol; 1979 Dec; 31(12):861-3. PubMed ID: 43377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.